Pinnacle Wealth Planning Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,736
Closed -$224K 547
2024
Q3
$224K Sell
15,736
-1,624
-9% -$23.1K 0.03% 420
2024
Q2
$225K Sell
17,360
-1,275
-7% -$16.5K 0.03% 380
2024
Q1
$259K Sell
18,635
-2,907
-13% -$40.4K 0.04% 343
2023
Q4
$307K Sell
21,542
-67
-0.3% -$956 0.05% 263
2023
Q3
$334K Buy
21,609
+2,889
+15% +$44.7K 0.06% 230
2023
Q2
$294K Sell
18,720
-933
-5% -$14.7K 0.05% 264
2023
Q1
$324K Sell
19,653
-3,625
-16% -$59.7K 0.05% 252
2022
Q4
$363K Buy
23,278
+3,316
+17% +$51.7K 0.06% 222
2022
Q3
$259K Sell
19,962
-9,692
-33% -$126K 0.05% 269
2022
Q2
$416K Buy
29,654
+5,726
+24% +$80.3K 0.07% 182
2022
Q1
$343K Sell
23,928
-8,760
-27% -$126K 0.06% 246
2021
Q4
$445K Buy
32,688
+4,146
+15% +$56.4K 0.09% 175
2021
Q3
$468K Buy
28,542
+651
+2% +$10.7K 0.1% 153
2021
Q2
$469K Buy
27,891
+2,025
+8% +$34.1K 0.11% 141
2021
Q1
$472K Buy
25,866
+2,535
+11% +$46.3K 0.12% 133
2020
Q4
$425K Buy
23,331
+5,563
+31% +$101K 0.1% 127
2020
Q3
$317K Buy
17,768
+439
+3% +$7.83K 0.1% 158
2020
Q2
$310K Sell
17,329
-5,658
-25% -$101K 0.1% 156
2020
Q1
$348K Sell
22,987
-967
-4% -$14.6K 0.17% 123
2019
Q4
$472K Buy
23,954
+1,112
+5% +$21.9K 0.22% 92
2019
Q3
$392K Buy
22,842
+2,564
+13% +$44K 0.21% 93
2019
Q2
$359K Buy
20,278
+1,593
+9% +$28.2K 0.22% 92
2019
Q1
$381K Buy
+18,685
New +$381K 0.26% 76
2018
Q4
Sell
-31,176
Closed -$666K 186
2018
Q3
$666K Buy
31,176
+1,959
+7% +$41.8K 0.61% 43
2018
Q2
$611K Buy
29,217
+4,916
+20% +$103K 0.59% 51
2018
Q1
$593K Buy
+24,301
New +$593K 0.61% 50